HYPERPLASIA OF THE FEMALE REPRODUCTIVE ORGANS IN UKRAINE.

Ukraine breast hyperplasia cervical hyperplasia ovarian hyperplasia risk factors surgical site infection

Journal

Wiadomosci lekarskie (Warsaw, Poland : 1960)
ISSN: 0043-5147
Titre abrégé: Wiad Lek
Pays: Poland
ID NLM: 9705467

Informations de publication

Date de publication:
2023
Historique:
medline: 17 4 2023
entrez: 14 4 2023
pubmed: 15 4 2023
Statut: ppublish

Résumé

The aim: To determine the role of infectious diseases as the cause of the Cervical, Ovarian and Breast hyperplasia in Ukraine. Materials and methods: We conducted a retrospective multicenter cohort study from January 1st, 2020 to December 31st, 2022. This study included patients aged 20-59 years with a diagnosis of hyperproliferative pathology of the women reproductive organs without atypia, who sought medical care for hyperplastic processes admitted to the 12 hospitals from 9 regions of Ukraine. Results: We had examined 4,713 women; out of which 81.1% met the clinical definition of female reproductive organs hyperplasia. Of all hyperplasia cases, most frequently recorded types were breast hyperplasia (41,7%), followed by cervical hyperplasia (31,1%) and ovarian hyperplasia (27,2%). History of Cervicitis (p<0.001), Vaginal cuff infection (p<0.001), Oophoritis (p<0.001), and Mastitis (p<0.001) were identified as independent risk factors of Cervical, Ovarian and Breast hyperplasia. Conclusions: This study showed that surgical site infections after obstetric and gynecological operations are is the cause of Cervical, Ovarian and Breast hyperplasia. Therefore, early detection and treatment SSIs can reduce the risk of hyperplasia these organs.

Identifiants

pubmed: 37057766
doi: 10.36740/WLek202303101
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

467-473

Auteurs

Aidyn G Salmanov (AG)

SHUPYK NATIONAL HEALTHCARE UNIVERSITY OF UKRAINE, KYIV, UKRAINE; INSTITUTE OF PEDIATRICS, OBSTETRICS AND GYNECOLOGY OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE, KYIV, UKRAINE.

Volodymyr Artyomenko (V)

ODESA NATIONAL MEDICAL UNIVERSITY, ODESA, UKRAINE.

Svitlana Y Hladenko (SY)

SUMY STATE UNIVERSITY, SUMY, UKRAINE.

Irina M Koctjuk (IM)

NATIONAL PIROGOV MEMORIAL MEDICAL UNIVERSITY, VINNYTSIA, UKRAINE.

Andrii O Marchenko (AO)

ODESA REGIONAL CLINICAL ANTITUMOR CENTER, ODESA, UKRAINE.

Galina O Tolstanova (GO)

SHUPYK NATIONAL HEALTHCARE UNIVERSITY OF UKRAINE, KYIV, UKRAINE.

Svitlana M Korniyenko (SM)

ODESA NATIONAL MEDICAL UNIVERSITY, ODESA, UKRAINE.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH